June 15, 2020 Price forecast | 2 weeks: 0.19% | 1 month: -2.89% | 3 months: -5.70%


ALT stock forecast

Our latest prediction for Altimmune, Inc.'s stock price was made on the June 15, 2020 when the stock price was at 7.60$.

In the short term (2weeks), ALT's stock price should outperform the market by 0.19%. During that period the price should oscillate between -11.33% and +15.32%.

In the medium term (3months), ALT's stock price should underperform the market by -5.70%. During that period the price should oscillate between -39.56% and +32.00%.

Create a solid portfolio with ALT

Add ALT to your portfolio and optimize it!


About Altimmune, Inc.

Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.

At the moment the company generates 5M USD in revenues.

On its last earning announcement, the company reported a loss of -1.59$ per share.

The book value per share is 24.98$

Altimmune, Inc. website


Three months stock forecastJune 15, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
5M 100.00% -25M -503.00% -22M -1.59 - - 15M 24.98 -12M - -12M